| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.26▼ | 1.26▼ | 1.25▼ | 1.30▼ | 1.40▼ |
| MA10 | 1.26▼ | 1.26▼ | 1.26▼ | 1.36▼ | 1.45▼ |
| MA20 | 1.26▼ | 1.30▼ | 1.31▼ | 1.44▼ | 1.57▼ |
| MA50 | 1.33▼ | 1.37▼ | 1.37▼ | 1.47▼ | 2.18▼ |
| MA100 | 1.37▼ | 1.42▼ | 1.45▼ | 1.59▼ | 3.41▼ |
| MA200 | 1.41▼ | 1.46▼ | 1.47▼ | 1.93▼ | 8.44▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.004▲ | -0.001▼ | -0.005▼ | -0.025▼ | 0.017▲ |
| RSI | 38.881▼ | 35.935▼ | 35.792▼ | 34.000▼ | 33.604▼ |
| STOCH | 62.500 | 59.268 | 34.295 | 17.124▼ | 22.294 |
| WILL %R | -50.000 | -69.231 | -77.143▼ | -91.111▼ | -93.750▼ |
| CCI | -26.667 | -85.243 | -78.642 | -153.690▼ | -177.252▼ |
|
Thursday, November 06, 2025 05:29 AM
Perfect Moment Ltd. (NYSE American: PMNT) ("Perfect Moment" or the "Company"), the high-performance luxury lifestyle brand that fuses technical excellence with fashion-led designs, today announces its ...
|
|
Friday, October 24, 2025 07:20 AM
(per RECIST v1.1) at the 100 mg APR-1051 dose level in heavily pretreated gastrointestinal and gynecologic malignancies Disease stabilization observed in patients with tumors harboring mutations ...
|
|
Tuesday, October 14, 2025 01:00 AM
DOYLESTOWN, Pa., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage biopharmaceutical company developing innovative treatments that ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 07/11/25 | 1.23 | 1.29 | 1.2201 | 1.23 | 36,246 |
| 06/11/25 | 1.31 | 1.33 | 1.19 | 1.20 | 44,406 |
| 05/11/25 | 1.36 | 1.38 | 1.31 | 1.312 | 73,911 |
| 04/11/25 | 1.36 | 1.40 | 1.36 | 1.37 | 39,876 |
| 03/11/25 | 1.40 | 1.45 | 1.39 | 1.40 | 51,457 |
| 31/10/25 | 1.45 | 1.46 | 1.39 | 1.40 | 47,163 |
| 30/10/25 | 1.44 | 1.47 | 1.40 | 1.45 | 40,998 |
| 29/10/25 | 1.45 | 1.49 | 1.41 | 1.45 | 92,606 |
| 28/10/25 | 1.31 | 1.43 | 1.31 | 1.42 | 98,936 |
| 27/10/25 | 1.41 | 1.43 | 1.32 | 1.34 | 189,667 |
|
|
||||
|
|
||||
|
|